Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP664165.RAiE0KBOt5H_pPhIk4OSjh7St34bKV4jtLApcY6DzI8YA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP664165.RAiE0KBOt5H_pPhIk4OSjh7St34bKV4jtLApcY6DzI8YA130_assertion type Assertion NP664165.RAiE0KBOt5H_pPhIk4OSjh7St34bKV4jtLApcY6DzI8YA130_head.
- NP664165.RAiE0KBOt5H_pPhIk4OSjh7St34bKV4jtLApcY6DzI8YA130_assertion description "[The results of this study on familial and unselected breast, ovarian, colorectal, and prostate cancer patients suggest that RAD51D is primarily a moderate penetrance susceptibility gene for ovarian cancer, with clinical significance for the carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP664165.RAiE0KBOt5H_pPhIk4OSjh7St34bKV4jtLApcY6DzI8YA130_provenance.
- NP664165.RAiE0KBOt5H_pPhIk4OSjh7St34bKV4jtLApcY6DzI8YA130_assertion evidence source_evidence_literature NP664165.RAiE0KBOt5H_pPhIk4OSjh7St34bKV4jtLApcY6DzI8YA130_provenance.
- NP664165.RAiE0KBOt5H_pPhIk4OSjh7St34bKV4jtLApcY6DzI8YA130_assertion SIO_000772 22652533 NP664165.RAiE0KBOt5H_pPhIk4OSjh7St34bKV4jtLApcY6DzI8YA130_provenance.
- NP664165.RAiE0KBOt5H_pPhIk4OSjh7St34bKV4jtLApcY6DzI8YA130_assertion wasDerivedFrom befree-20150227 NP664165.RAiE0KBOt5H_pPhIk4OSjh7St34bKV4jtLApcY6DzI8YA130_provenance.
- NP664165.RAiE0KBOt5H_pPhIk4OSjh7St34bKV4jtLApcY6DzI8YA130_assertion wasGeneratedBy ECO_0000203 NP664165.RAiE0KBOt5H_pPhIk4OSjh7St34bKV4jtLApcY6DzI8YA130_provenance.